AbbVie sweeps up inflammatory-focused Celsius for $250M cash in summer heat wave

cafead

Administrator
Staff member
  • cafead   Jun 27, 2024 at 11:32: AM
via AbbVie is embracing summer’s heat, cranking up the M&A dial with the acquisition of inflammatory disease-focused Celsius Therapeutics for $250 million cash.

article source